Wellbutrin XL News

UPDATE 3-Biovail settles US shareholder suit - Reuters

The case centered on claims Biovail made regarding its two key products, Cardizem LA and Wellbutrin XL. Still, the company said the pact "contains no ...

http://www.reuters.com/article/he... | Posted: Tue Dec 11 12:51:57 -0500 2007

Teva's Heartburning Battle - Motley Fool

... to wait on other doses, like it did in its agreement with Biovail (NYSE: BVF) and GlaxoSmithKline (NYSE: GSK) over their antidepressant Wellbutrin XL. ...

http://www.fool.com/investing/hig... | Posted: Wed Dec 26 14:24:12 -0500 2007

Teva's horizon - Globes

There are three major drugs in the US on which Teva can win exclusivity even if it shares it with other companies - Wellbutrin XL, Lamictal, and Fosamax and ...

http://www.globes.co.il/serveen/g... | Posted: Tue Dec 18 11:12:46 -0500 2007

Biovail to Pay $138 Million to Settle Investor Suit (Update2) - Bloomberg

Biovail shares slumped 68 percent from June to December in 2003, as earnings fell after the company lost a shipment of its Wellbutrin XL antidepressant and ...

http://www.bloomberg.com/apps/new... | Posted: Tue Dec 11 15:22:46 -0500 2007

Biovail settles US class action suit - Reuters Canada

The case centered around claims the company made regarding its two key products, Cardizem LA and Wellbutrin XL. Still, the company cautioned that the ...

http://ca.today.reuters.com/news/... | Posted: Tue Dec 11 08:53:16 -0500 2007

Toronto stocks seen cautious ahead of Fed decision - Reuters Canada

... about $85 million to settle a US securities class action suit that stretched back more than 4 years involving its Wellbutrin XL and Cardizem LA products.

Posted: Tue Dec 11 09:12:00 -0500 2007

Biovail CCR cut to 'BB' with stable outlook on weakening business ... - CNNMoney.com

'The downgrade reflects a weakening of the business risk profile caused by delays in obtaining FDA approval for the new salt formulation of Wellbutrin XL, ...

http://money.cnn.com/news/newsfee... | Posted: Fri Dec 07 02:27:26 -0500 2007

Biovail, Watson reach pact to delay generic drug - Reuters

Earlier this year, Biovail reached a patent settlement with a number of companies over its key anti-depressant drug Wellbutrin XL, delaying a flood of ...

http://www.reuters.com/article/he... | Posted: Thu Dec 06 17:59:49 -0500 2007

Is your craving for carbs and sleep a natural response to a lack ... - Kansas.com

Buproprion (Wellbutrin XL) has Food and Drug Administration approval for SAD. Other common antidepressants also may be used. Most people start feeling ...

http://www.kansas.com/298/story/2... | Posted: Tue Dec 04 02:08:22 -0500 2007